165 results about "Glycerol phosphate" patented technology

The invention provides a method for synthesizing isoprene from pyruvic acid and 3-phosphoglyceraldehyde, and a reconstituted cell. The pyruvic acid and the 3-phosphoglyceraldehyde are finally obtained from simple starting materials such as glucose.

The invention relates to a method for improving the yield of arginine by the mutation of Corynebacterium crenatum N-acetyl glutamic acid kinase. L-arginine is one of semi-essential basic amino acids for a human body, and has various particular physiology and pharmacology functions. High-yield arginine mutant strain C. crenatum SYPA5-5 is compounded into the arginine through a circulating way, and N-acetyl glutamic acid kinase (NAGK) is a key enzyme in the compounding way and is subject to the feedback inhibition of the product arginine. By using an overlapping PCR (Polymerase Chain Reaction) technique, a GAT (glycerol phosphate acyl transferase) codon used for coding aspartic acid is used for substituting a GGA (General Gonadotropic activity) codon used for coding glycine at the site 287 in the coding NAGK albumen, and the NAGK which has high activity and arginine with obviously reduced by the feedback inhibition can be obtained after the mutation. An argBSD gene is brought into the Corynebacterium crenatum of the high-yield arginine through pJCl-tac, and the expression volume of the key enzyme is further improved. The final acid yield is increased to 36.3g/L from original 28g/L, and the yield of the L-arginine is increased by 29.7 percent.

The present invention provides a mesenchymal stem cell ossification osteogenic differentiation culture medium, and belongs to the technical field of stem cells. The mesenchymal stem cell ossification osteogenic differentiation culture medium comprises a DMEM/F12 culture medium, and further comprises FBS with a volume percentage of 5-50%, glutamine with a volume percentage of 0.5-5%, antibiotic with a volume percentage of 0.5-5%, 100-1000 [mu]M ascorbic acid, 5-50 mM glycerol phosphate, 5-50 nM dexamethasone, 5-50 [mu]M resveratrol, and 0.05-0.5 [mu]M puerarin. The mesenchymal stem cell ossification osteogenic differentiation culture medium of the present invention has advantages of high inducing efficiency and the like.

The invention provides a recombinant plasmid, a multi-titer live vaccine as well as preparation methods and the application thereof. The provided recombinant plasmid contains a fusion gene sequence ofsignal peptides of vibrio anguillarum metalloprotease and aeromonas hydrophila 3-glycerophosphate dehydrogenase; the preparation method of the recombinant plasmid comprises the following steps: (A) establishing signal peptide-3-glycerophosphate dehydrogenase fusion gene; (B) enzyme-cutting the fusion gene and a carrier; and (C) connecting the enzyme-cutting fusion gene and the enzyme-cutting carrier. The multi-titer live vaccine is prepared by converting the recombinant plasmid into vibrio anguillarum attenuated strains; and the preparation method of the multi-titer live vaccine comprises thefollowing steps: (A) establishing the recombinant plasmid containing signal peptides of vibrio anguillarum metalloprotease and aeromonas hydrophila 3-glycerophosphate dehydrogenase; and (B) converting the recombinant plasmid obtained in the step (A) into vibrio anguillarum attenuated strains. The multi-titer live vaccine is applied to prevent and treat fish diseases caused by vibrio anguillarum and aeromonas hydrophila. The attenuated vaccine provided by the invention has remarkable multi-titer immune protective efficiency, can be used as the live vaccine of vibrio anguillarum and aeromonas hydrophila and has favorable application prospect.

The invention discloses genetic engineering bacteria producing beta- carotene and a construction method of the genetic engineering bacteria. The construction method comprises the following steps of firstly knocking out alpha-glycerophosphate dehydrogenase gut2 genes in a glycolysis way in a beta-carotene synthetizing pathway in yarrowia lipolytica, then performing free expression on beta-hydroxyl-beta-methylglutaric acid erg13 genes having two endogenous copy numbers of the yarrowia lipolytica, and then performing integrant expression on the erg13 genes having two endogenous copy numbers of the yarrowia lipolytica at the position where the gut2 genes are knocked out; and performing free expression on endogenous hexokinase Hxk genes of the yarrowia lipolytica, and screening positive transformants to obtain the engineering bacterial strains producing beta-carotene yarrowia lipolytica. The bacterial strains are subjected to fermentation, culturing, extraction and separation, the beta-carotene is purified, and the content of the beta-carotene can reach 26.6mg/g cell dry weight.

The invention relates to a composition for enhancing the water solubility of curcumin and a preparation method of the composition and belongs to the technical field of foods and health-care products.The composition provided by the invention comprises the following components in parts by weight: 0.1 to 35.0 parts of the curcumin or a derivative thereof, 0.03 to 560.0 parts of phospholipid containing glycerol phosphate or the glycerol phosphate and 0.2 to 70.0 part of resistant dextrin. In the composition provided by the invention, the dissolution rate and the releasing rate of the composition,and the in-vivo transportation efficiency and the bioavailability of the curcumin are cooperatively enhanced through the glycerol phosphate and the resistant dextrin, and the intestinal absorption condition of the lipid-soluble curcumin is improved; and the types and forms, and a functional application range of a curcumin solid preparation are expanded under the condition that original propertiesand anti-oxidization performance of the curcumin are not influenced.

The invention belongs to the technical field of antibiosis, particularly relates to an antibacterial silver ion compound, which further relates to a non-irritant silver ion antibacterial agent as wellas a preparation method and an application thereof. The cationic ions in the antibacterial silver ion compound are coordination cations formed by silver ions and amino acid ligands. The amino acid ligand is selected from amino acid and/or polypeptide, and the anion is selected from one or more of acetate radical, hydrogen phosphate radical, dihydrogen phosphate radical, glycerol hydrogen phosphate radical, glycerol phosphate radical, lactate radical, glycolate radical, tartrate radical, citrate radical and malate radical. The antibacterial silver ion compound disclosed by the invention has good stability and compatibility, does not generate decomposition discoloration after being placed for a long time, does not have unpleasant odor, has good salt tolerance and is non-irritant. The antibacterial agents such as antibacterial liquid, antibacterial gel and the like prepared by taking the antibacterial silver ion compound as an active ingredient have better antibacterial property, are non-irritant and can be in direct contact with a human body.

The invention provides a triglyceride determination kit. The kit comprises a liquid single reagent R1, the reagent R1 includes the following components with concentration: lipoprotein esterase, glycerol kinase, glycerol phosphate oxidase, peroxidase, piperazine-1,4-diethanesulfonic acid, NaOH, 4-aminoantipyrine, adenosine triphosphate, N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3-methylaniline sodium orN-ethyl-N-(2-hydroxy-3-propyl)-3'5-dimethoxyaniline sodium salt, sodium glutamate, magnesium acetate, flavin adenine dinucleotide, polyethylene glycol, and a betaine solution. The kit belongs to the technical field of biological detection, and the triglyceride determination kit provided by the invention significantly enhances the anti-interference ability while improving the stability of the reagent, and has good measurement accuracy for triglyceride.

The invention discloses a collagen polypeptide skin care mask and a preparation method thereof. The mask comprises collagen polypeptide skin care mask cream and a mask carrier, wherein the mask creamis prepared from the following components by mass: 20-40 parts of butanediol, 10-15 parts of glycerol, 1-3 parts of betaine, 0.2-1 part of lactobacillus fermentation product, 0.2-1 part of panthenol,0.2-1.2 parts of sodium hyaluronate, 0.1-1 part of tocopherol, 2-5 parts of collagen, 0.3-2 parts of bishydroxymethyl imidazolidinyl urea, 0.3-0.8 part of allantoin, 0.1-1.2 parts of carbomer, 0.2-1 part of triethanolamine, 0.5-1 part of methylparaben, 1-5 parts of sclerotium gum, 0.1-1 part of glycerol phosphate inositol choline salt, 1-1.5 parts of oligopeptide-1, 1-1.5 parts of oligopeptide-2,0.4-1.5 parts of oligopeptide-5, 0.8-2 parts of EDTA disodium, 0.4-1 part of PEG-40 hydrogenated castor oil, 0.1-0.5 part of essence and 50-60 parts of water. The preparation method is used for preparing the collagen polypeptide skin care mask.

The invention discloses temperature/pH double-response type hydrogel and a preparation method thereof. The method comprises the following steps: preparing partial chitosan; preparing a chitin nano fiber dispersion; slowly dropwise adding and mixing a water phase, an oil phase and a surfactant according to a proportion, and continuously stirring for 2-72 hours to obtain a clear transparent oil-in-water microemulsion; uniformly mixing the chitin nano fiber dispersion, the microemulsion, beta-phosphoglycerol and a biological complex factor according to a proportion, and performing alkaline coagulating bath to obtain the temperature/pH double-response type hydrogel. In the invention, the temperature/pH double-response type hydrogel is prepared by compounding the beta-GP and the biological complex factor with the chitin nano fiber, and the preparation method is simple and has strong operability. The temperature/pH double-response type hydrogel has good mechanical property, biocompatibility,temperature responsiveness, pH responsiveness and slow release property, and can be applied to the medical fields such as slow release of drugs, and thus has a good application prospect.

The invention relates to the field of biological materials, and provides a preparation method of a temperature-sensitive chitosan hydrogel cell factor composite stent. According to the technical scheme, the preparation method of the temperature-sensitive chitosan hydrogel cell factor composite stent comprises the following steps: 1) mixing chitosan with gelatin at a mass ratio of 2.5: 0.8-1.2; 2)dissolving a mixture obtained from step 1) in an acetic acid solution with the concentration being 0.1 M or an aqueous solution, and blending for 24 hours or above at the temperature of 4 DEG C; 3) dropwise adding a glycerol phosphate disodium salt solution with the concentration being 44.4% into a mixture obtained from step 2), and adding in an ultra-clean table at the temperature of 4 DEG C while stirring, wherein the mass ratio of glycerol phosphate disodium salt to the mixture is 1: 0.5-1.0; 4) dropwise adding cell factors in the mixture obtained from step 3), and adding in the ultra-cleantable at the temperature of 4 DEG C while stirring; and 5) maintaining the mixture obtained from step 4) at 4 DEG C in a liquid state, and solidifying into solid gel at 37 DEG C 10 minutes later. Thestent obtained by the method can slowly release cell factors.

The invention discloses a soilless cultivation nutrient formula of peonies. The soilless cultivation nutrient formula is composed of, by weight, 13-16.5 parts of diphenylamine, 11.5-12.5 parts of ammonium ferric sulfate, 2-20 parts of auxin, 4-5 parts of methionine, 0.4-0.8 part of barium sulfide, 0.1-0.3 part of barium vanadate, 0.1-0.3 part of iodine pentafluoride, 0.05-0.2 part of glycerol phosphate calcium and the balance water. The soilless cultivation nutrient formula is made by weighing and evenly mixing the ingredients according to the ratio. By the adoption of the nutrient liquid, the seepage force and diffusivity of the nutrient liquid are greatly enhanced in the breeding process, so that the seeding stage is greatly shortened, the emergence rate is increased, the quality of emergence is improved, and meanwhile the cost is lowered; the nutrient liquid is more suitable for high-altitude low-temperature seedling cultivation.

The invention relates to a method for expressing a bovine-derived trypsinogen gene in Pichia pastoris by gene recombination. The recombinant bovine trypsinogen is expressed in Pichia pastoris by the novel promoter and secreted into the culture medium; the zymogen is self-activated, or treated by enterokinase or trypsinase or the like to prepare the active bovine trypsinase; and the prepared active bovine trypsinase can be used for producing the recombinant human insulin and human insulin analogs. The method can avoid the defects in the constitutive promoter glyceraldehyde-3-phosphate dehydrogenase (GAP) promoter and the induction-type promoter alcohol oxidase (AOX1) promoter.

The production process of transgenic rape as sinapic acid bioreactor includes the steps of: cloning phosphoenolpyruvate carboxyilase gene PEP segment and constituting it into Anti-PEG gene plant expression vector, introducing Anti-PEP gene into rape genome through gene conversion process to obtain "high-oil rape" with efficient oil synthesizing rape seed; preparing lytic phosphatidic acid acyltransferase (LPAAT) gene capable of connecting sinapic acid to the sn-2 site of 3-glycerol phosphate and connecting it to plant expression vector promoter to constitute LPAAT gene plant expression vector; introducing LPAAT gene into rape genome to obtain "high-sinapic acid rape" with efficient sinapic acid and 3-glycerol phosphate combining seed; crossbreeding "high-oil rape" and "high-sinapic acid rape" to obtain F1 generation rape plant with both "high-oil rape" characteristic and "high-sinapic acid rape" characteristic.

The invention relates to a recombinant Mortierella alpine strain GPD-1 overexpressing G3PD1 and a construction method. According to the invention, uracil-auxotrophic Mortierella alpine MAU1 is used as a material, Agrobacterium tumefaciens is used for mediation, and a G3PD1-overexpressing recombinant strain with obviously increased lipid content is obtained. Compared with wild Mortierella alpine, the total lipid content of the strain provided in the invention is increased by about 50%, and the transcription amount of G3PD1 is increased by about 2 times; so theoretical and application foundations are laid for subsequent industrial application.

The invention relates to D-3-phosphoglycerate-dehydrogenase and a coding gene thereof. The amino acid sequence of the D-3-phosphoglycerate-dehydrogenase is shown as a sequence 1; the inhibition constant Ki of L-serine of the D-3-phosphoglycerate-dehydrogenase is greater than 250mM; and the sequence of the coding gene is shown as a sequence 2. The difference between the amino acid sequence of the D-3-phosphoglycerate-dehydrogenase (PGDH) provided by the invention and the amino acid sequence (sequence 3) of the escherichia coli wild type PGDH lies in that amino acid at 344th site is not histidine but lactamine and amino acid at 346th site is not asparagines but lactamine and the PGDH generated by mutation is not inhibited by the L-serine. In addition, the enzyme activity of a PGDH variant disclosed by the invention has no change compared with the wild type PGDH variant.

The invention provides a nucleoside high-yielding strain as well as a construction method and application thereof. The invention also provides a method for producing nucleoside by fermentation. The method comprises the following steps of (1) enhancing a serine hydroxymethyltransferase gene glyA, as shown in SEQ ID NO:2, of bacillus subtilis; and/or (2) weakening a 2,3-diphosphoglyceric acid independent phosphoglyceric acid mutant enzyme gene pgm of a coded NCBI reference sequence WP_003228330.1 on a chromosome of the bacillus subtilis; and (3) applying the strain obtained in the step (1) and/or the step (2) to fermentation production of the nucleoside. The engineered strain bacillus subtilis provided by the invention is the nucleoside high-yielding strain, can effectively accumulate the nucleoside, improves the yield of the nucleoside, and lays a foundation for industrial production of the nucleoside.

The invention relates to a reagent (kit) for measuring formaldehyde by using an enzyme-multiplied method, an enzyme colorimetric method and an enzyme coupling method as well as a method for measuring the concentration of the formaldehyde, and composition and ingredients of the reagent, belonging to the technical field of food/environmental test. The reagent (kit) comprises the main ingredients of buffer solution, coenzyme, adenosine triphosphoric acid, tetrahydrofolic acid, glyceric aldehyde-3-phosphoric acid, formaldehyde dehydrogenase, formic acid-dihydrofolic acid ligase, glyceric aldehyde-3-glycerol phosphate dehydrogenase and stabilizing agent. The concentration of the formaldehyde is measured by mixing a sample and the reagent according to a certain volume ratio to carry out a series of enzymatic reaction, placing the reactant under an ultraviolet/visible light analyzer and detecting the ascending degree of absorbance at a dominant wavelength of 340nm.

The invention relates to an electrolyte and glucose compound injection for children and a preparation method of the electrolyte and glucose compound injection. 1000 ml of the injection is prepared from 0.1-0.3 g of sodium chloride, 2.5-3.0 g of sodium acetate trihydrate, 1.1-1.4 g of potassium chloride, 0.1-0.2 g of calcium chloride dihydrate, 0.2-0.4 g of magnesium chloride hexahydrate, 0.02-0.03g of malic acid, 1.4-1.6 g of glycerol phosphate disodium salt pentahydrate, 45-55 g of glucose, 1.0-1.2 g of 25% hydrochloric acid and 5.0-5.5 g of a pH regulator. The preparation process of the injection comprises the following steps: solution preparation, filtering, filling, capping, sterilization and light inspection, wherein solution preparation adopts combination of concentrated preparationand dilute preparation, low temperature is adopted in a concentrated preparation process, nitrogen introduced dark protection is adopted in the whole solution preparation process, and influence of activated carbon on quality of the injection can be avoided effectively by enhancing control of raw and auxiliary materials and a packing material. The electrolyte and glucose compound injection prepared with the method has good drug stability and few side reactions, medication compliance and safety of a patient are high, and the injection is more applicable to water and electrolyte balance of newborn and children of 2 years old or younger in a perioperative period.